Exozymes Inc. $EXOZ

What the company doesAI summary of filing

eXoZymes Inc. develops cell-free biomanufacturing technology using engineered enzymes called exozymes to produce valuable chemicals, including active pharmaceutical ingredients, nutraceuticals, and biofuels. The company is pre-revenue and development-stage, focusing initially on nutraceutical products with pharmaceutical potential, particularly N-trans-caffeoyltyramine (NCT), while also pursuing an isobutanol program for sustainable aviation fuel with government grant funding. eXoZymes plans to commercialize its technology platform through spinouts, joint ventures, and licensing partnerships with established companies that have manufacturing expertise and market access. The company has received $17.7 million in government grants from the Department of Energy and National Institutes of Health, among other sources, to advance its research and develop biosolutions. [10-K 2026-03-30]

Segments: Nutraceutical products (NCT), Pharmaceutical development, Isobutanol/biofuels, Enzyme and exozyme production services